AI brief of an SEC Form 8-K · Eastman Chemical (EMN)

Eastman Chemical signs severance agreement with executive Brad A. Lich

Neutral Impact 2 of 5 leadership Written later

Eastman Chemical entered a severance agreement with Brad A. Lich dated March 10, 2025, setting out benefits if he is terminated without Cause or resigns for good reason after March 1, 2027. The filing describes a $2 million cash severance payment plus up to four months of company-paid healthcare, and it does not say whether Lich holds a new or changed role.

Key points

  • Agreement with Brad A. Lich dated March 10, 2025
  • Qualifying triggers: termination without Cause, or good-reason resignation after March 1, 2027
  • Cash severance of $2 million plus amounts under existing company plans, and up to four months of paid healthcare coverage
  • Full agreement to be filed with the Form 10-Q for first quarter 2025

The filing

CompanyEastman Chemical (EMN)
Form8-K, current report
Filed with the SECMar 14, 2025, 4:15 PM ET
Accession number0001193125-25-054808

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 14, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.